These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22586871)

  • 21. Pharmaceutical sales of pseudoephedrine: the impact of electronic tracking systems on methamphetamine crime incidents.
    Mazerolle L; McGuffog I; Ferris J; Chamlin MB
    Addiction; 2017 Mar; 112(3):468-474. PubMed ID: 27741563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second generation mephedrone. The confusing case of NRG-1.
    Brandt SD; Sumnall HR; Measham F; Cole J
    BMJ; 2010 Jul; 341():c3564. PubMed ID: 20605894
    [No Abstract]   [Full Text] [Related]  

  • 23. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories.
    Grant P; Bell K; Stewart D; Paulson J; Rogers K
    Pediatr Emerg Care; 2010 Jan; 26(1):10-4. PubMed ID: 20042914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Foreword.
    Leikin JB
    Dis Mon; 2012 Feb; 58(2):37. PubMed ID: 22251898
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of methamphetamine precursor regulations.
    McKetin R; Sutherland R; Bright DA; Norberg MM
    Addiction; 2011 Nov; 106(11):1911-24. PubMed ID: 21895829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions.
    Callaghan RC; Cunningham JK; Victor JC; Liu LM
    Drug Alcohol Depend; 2009 Dec; 105(3):185-93. PubMed ID: 19699042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Information from your family doctor. Meth abuse: what you should know.
    American Academy of Family Physicians
    Am Fam Physician; 2007 Oct; 76(8):1175-6. PubMed ID: 17990841
    [No Abstract]   [Full Text] [Related]  

  • 33. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug impairment reviews: stimulants.
    Forney R
    NIDA Res Monogr; 1977 Mar; Series 11():73-6. PubMed ID: 19705
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacological action of pseudoephedrine salicylate on the central nervous system of mice].
    Yan L; Jin SJ; Wang R; Jiang YX; Liu LJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):665-7. PubMed ID: 15460414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The York Region Methamphetamine Strategy.
    Cronkwright Kirkos W; Carrique T; Griffen K; La Barge AP
    CMAJ; 2008 Jun; 178(13):1655-6. PubMed ID: 18559801
    [No Abstract]   [Full Text] [Related]  

  • 37. Import and production quotas for certain List I chemicals. Interim final rule with request for comment.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2007 Jul; 72(131):37439-53. PubMed ID: 17674492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats.
    Suzuki T; Fukuoka Y; Mori T; Miyatake M; Narita M
    Eur J Pharmacol; 2004 Sep; 498(1-3):157-61. PubMed ID: 15363990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions.
    Cunningham JK; Liu LM
    Addiction; 2003 Sep; 98(9):1229-37. PubMed ID: 12930210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian behavioral rhythms in Cry1/Cry2 double-deficient mice induced by methamphetamine.
    Honma S; Yasuda T; Yasui A; van der Horst GT; Honma K
    J Biol Rhythms; 2008 Feb; 23(1):91-4. PubMed ID: 18258761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.